Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Hemming

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|November 15, 2008
Primary human hepatocyte culture for HCV studyHaizhen Zhu, John Elyar, Robin Foss, et al.
Gastroenterology|November 7, 2007
Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense systemHaizhen Zhu, Huijia Dong, Erika Eksioglu, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 13, 2004
Thiopurine S-methyltransferase genotype predicts azathioprine-induced myelotoxicity in kidney transplant recipientsChristine M Formea, Heather Myers-Huentelman, Rongling Wu, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 30, 2007
Effect of prophylaxis on fungal infection and costs for high-risk liver transplant recipientsAlan Reed, Jill Boylston Herndon, Nail Ersoz, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 24, 2004
Splenic transposition is superior to caudal shunt as a model of murine total hepatic ischemiaTadashi Matsumoto, Philip A Efron, Hironori Tsujimoto, et al.
Annals of Surgery|August 3, 2022
Ex Vivo Liver Resection and Autotransplantation: Should It be Used More Frequently?Joshua Weiner, Alan Hemming, David Levi, et al.
Abdominal Radiology (New York)|November 1, 2017
Technical report: gadoxetate-disodium-enhanced 2D R2* mapping: a novel approach for assessing bile ducts in living donorsSoudabeh Fazeli Dehkordy, Kathryn J Fowler, Tanya Wolfson, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 9, 2002
Combination of interferon alfa-2b and ribavirin in liver transplant recipients with histological recurrent hepatitis CRoberto J Firpi, Manal F Abdelmalek, Consuelo Soldevila-Pico, et al.
Journal of the American College of Surgeons|March 3, 2015
Surgical treatment of hepatocellular carcinoma in North America: can hepatic resection still be justified?William C Chapman, Goran Klintmalm, Alan Hemming, et al.
The Journal of Surgical Research|July 14, 2009
Development of quality indicators of care for patients undergoing hepatic resection for metastatic colorectal cancer using a Delphi processElijah Dixon, Christopher Armstrong, Guy Maddern, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Methods in Molecular Biology (Clifton, N.J.)|November 15, 2008
Primary human hepatocyte culture for HCV studyHaizhen Zhu, John Elyar, Robin Foss, et al.
Gastroenterology|November 7, 2007
Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense systemHaizhen Zhu, Huijia Dong, Erika Eksioglu, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 13, 2004
Thiopurine S-methyltransferase genotype predicts azathioprine-induced myelotoxicity in kidney transplant recipientsChristine M Formea, Heather Myers-Huentelman, Rongling Wu, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 30, 2007
Effect of prophylaxis on fungal infection and costs for high-risk liver transplant recipientsAlan Reed, Jill Boylston Herndon, Nail Ersoz, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 24, 2004
Splenic transposition is superior to caudal shunt as a model of murine total hepatic ischemiaTadashi Matsumoto, Philip A Efron, Hironori Tsujimoto, et al.
Annals of Surgery|August 3, 2022
Ex Vivo Liver Resection and Autotransplantation: Should It be Used More Frequently?Joshua Weiner, Alan Hemming, David Levi, et al.
Abdominal Radiology (New York)|November 1, 2017
Technical report: gadoxetate-disodium-enhanced 2D R2* mapping: a novel approach for assessing bile ducts in living donorsSoudabeh Fazeli Dehkordy, Kathryn J Fowler, Tanya Wolfson, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 9, 2002
Combination of interferon alfa-2b and ribavirin in liver transplant recipients with histological recurrent hepatitis CRoberto J Firpi, Manal F Abdelmalek, Consuelo Soldevila-Pico, et al.
Journal of the American College of Surgeons|March 3, 2015
Surgical treatment of hepatocellular carcinoma in North America: can hepatic resection still be justified?William C Chapman, Goran Klintmalm, Alan Hemming, et al.
The Journal of Surgical Research|July 14, 2009
Development of quality indicators of care for patients undergoing hepatic resection for metastatic colorectal cancer using a Delphi processElijah Dixon, Christopher Armstrong, Guy Maddern, et al.
Pageof 3